Join us for an exclusive fireside chat with Feng Zhang, PhD, renowned scientist and core member of the Broad Institute, an Investigator at the McGovern Institute for Brain Research, the James and Patricia Poitras Professor of Neuroscience at MIT, and a Howard Hughes Medical Institute Investigator, and Alex Aravanis, MD, PhD, CEO & Co-Founder of Moonwalk Biosciences. Previously, Dr. Aravanis was the CTO, and Head of R&D at Illumina. Together, they will explore the next frontier of genomics, AI-driven drug discovery and translation, and the breakthroughs shaping the future of medicine. This discussion will offer unique insights into target discovery applications of AI, unlocking medicines for the 99% of the genome that has not been effectively targeted, and accelerating the path from research to real-world therapies in large unmet needs.